Metrics as of 10/16/2026, 05:42 AM (Berlin time), refresh in progress.
Smith & Nephew Stock
Smith & Nephew plc
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- United Kingdom
- CEO
- Deepak S. Nath
- Employees
- 18,362
- Market cap
- $12.2 B
- IPO
- 16/11/1999
Smith & Nephew plc is a healthcare company based in Watford, United Kingdom. Founded in 1856, the company develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. With 18,362 employees, the firm serves healthcare providers globally. The…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
Smith & Nephew stock: price history
1D
+4.3%
1W
+7.9%
1M
+3.9%
6M
-14.0%
YTD
-11.3%
1Y
-17.8%
2Y
+2.2%
5Y
-17.8%
10Y
-5.4%
Next earnings date
Next earnings date
23/02/2027 (in 129 days)
Volatility around earnings
~61% stronger price swings than usual
Smith & Nephew stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 25/08/2026.
Ask the agents about Smith & Nephew
Analyst assessment of Smith & Nephew
PRICE TARGET LOW
US$30.00
CONSENSUS
US$31.91
MEDIAN
US$31.85
PRICE TARGET HIGH
US$33.88
0
STRONG BUY
6
BUY
15
HOLD
2
SELL
0
STRONG SELL
23
TOTAL · Hold
As of: 06/08/2026
Smith & Nephew stock metrics
P/E
19.12
P/B
2.37
EV/EBITDA
9.17
RETURN ON EQUITY
5.8%
NET MARGIN
9.8%
DEBT/EQUITY
0.73
DIVIDEND YIELD
2.7%
AS OF
27/06/2026
Free float & liquidity
FREE FLOAT
99.9%
FLOAT SHARES
418,279,201
AVG. DAILY VOLUME (30D)
1,424,467
Attention
1 mention today in US forums, about the same as yesterdayPrice since yesterday: +4.3%
Search (Google Trends)
Forums (Reddit)
Institutional holders
Dividends & Stock splits
Dividends
Stock splits
Comparable stocks
Frequently asked questions about Smith & Nephew stock
What does Smith & Nephew do?
Smith & Nephew plc is a company in the Healthcare sector, Medical - Devices industry, headquartered in United Kingdom.
The CEO is Deepak S. Nath, the company employs around 18,362 people.
The IPO was on 16/11/1999; the stock trades on NYSE under the ticker SNN.
What do analysts say about Smith & Nephew stock?
23 analysts rate the stock, the consensus is Hold (as of 06/08/2026).
The average price target is US$31.91, ranging from US$30.00 to US$33.88, with a median of US$31.85.
This is an external assessment, not a statement by Market Jury.
When does Smith & Nephew report next?
The next earnings date is 23/02/2027.
Around past earnings, price swings were roughly 61% stronger than usual.
Does Smith & Nephew pay a dividend?
Yes. The last dividend was US$0.31 per share, ex-date 02/10/2026, paid on 06/11/2026.
The dividend yield is 2.7% (as of 27/06/2026).
Which stocks are comparable to Smith & Nephew?
Comparable stocks include Smith & Nephew, LivaNova, Abbott Laboratories, Medtronic, Stryker, Boston Scientific, Edwards Lifesciences and Siemens Healthineers.
How can I get Smith & Nephew stock analyzed?
Clicking "Analyze stock" lets five strategies assess Smith & Nephew against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.